The Effects of Videogames on Depression Symptoms and Brain Dynamics

NCT05426265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1001

Last updated 2026-04-29

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the effects of a game-based digital-therapeutics (DTx) medical software device on the symptoms of depression in adults with confirmed major depressive disorder.

Conditions

Interventions

DEVICE

MEL-T01

A 12 week intervention with MEL-T01.

DEVICE

MEL-S01

A 12 week intervention with MEL-S01.

Sponsors & Collaborators

  • Business Finland

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Turku University Hospital

    collaborator OTHER_GOV
  • Aalto University

    lead OTHER

Principal Investigators

  • Hanna Renvall, PhD · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-28
Primary Completion
2024-08-14
Completion
2024-08-14

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05426265 on ClinicalTrials.gov